BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25783198)

  • 21. Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.
    Van't Westeinde SC; Horeweg N; De Leyn P; Groen HJ; Lammers JW; Weenink C; Nackaerts K; van Klaveren RJ
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):420-9. PubMed ID: 22491665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
    Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
    BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).
    Rasmussen JF; Siersma V; Pedersen JH; Brodersen J
    Lung Cancer; 2015 Jan; 87(1):65-72. PubMed ID: 25433982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
    Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
    Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China.
    Liu X; Liang M; Wang Y; Chen K; Chen X; Qin P; He J; Yi X
    Lung Cancer; 2011 Aug; 73(2):230-6. PubMed ID: 21168238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
    Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
    Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
    Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
    Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial.
    González Maldonado S; Motsch E; Trotter A; Kauczor HU; Heussel CP; Hermann S; Zeissig SR; Delorme S; Kaaks R
    Int J Cancer; 2021 Mar; 148(5):1097-1105. PubMed ID: 32930386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of Positive and Suspicious Findings in Clinical Computed Tomography Lung Cancer Screening and the Road Ahead.
    Regis SM; Borondy-Kitts A; McKee AB; Rieger-Christ K; Sands J; Afnan J; McKee BJ
    Ann Am Thorac Soc; 2022 Aug; 19(8):1371-1378. PubMed ID: 34818144
    [No Abstract]   [Full Text] [Related]  

  • 31. [Computed tomography screening for lung cancer].
    Becker N
    Radiologe; 2013 Sep; 53(9):757-63. PubMed ID: 23784616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening.
    McKee BJ; Regis S; Borondy-Kitts AK; Hashim JA; French RJ; Wald C; McKee AB
    J Natl Compr Canc Netw; 2018 Apr; 16(4):444-449. PubMed ID: 29632062
    [No Abstract]   [Full Text] [Related]  

  • 33. [Epidemiology of lung cancer].
    Becker N
    Radiologe; 2010 Aug; 50(8):654-61. PubMed ID: 20628726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NELSON lung cancer screening study.
    Ru Zhao Y; Xie X; de Koning HJ; Mali WP; Vliegenthart R; Oudkerk M
    Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S79-84. PubMed ID: 22185865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to minimize harms of lung cancer screening.
    Veronesi G
    J Thorac Oncol; 2014 Nov; 9(11):e83. PubMed ID: 25436811
    [No Abstract]   [Full Text] [Related]  

  • 36. The Role of Liquid Biopsies in Lung Cancer Screening.
    Dagogo-Jack I; Sequist LV; Piotrowska Z
    Semin Roentgenol; 2017 Jul; 52(3):185-187. PubMed ID: 28734402
    [No Abstract]   [Full Text] [Related]  

  • 37. [Scientific assessment and regulatory approval of radiological screening examinations in Germany].
    Hunger T; Nekolla E; Griebel J; Brix G
    Radiologe; 2021 Jan; 61(1):21-27. PubMed ID: 33044561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Lung Cancer.
    Tracer H; Pierre J
    Am Fam Physician; 2021 Jul; 104(1):79-80. PubMed ID: 34264608
    [No Abstract]   [Full Text] [Related]  

  • 39. Can autoantibody tests enhance lung cancer screening?-an evaluation of EarlyCDT
    González Maldonado S; Johnson T; Motsch E; Delorme S; Kaaks R
    Transl Lung Cancer Res; 2021 Jan; 10(1):233-242. PubMed ID: 33569307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT Screening for Lung Cancer: Successful Trial, but Failed Understanding.
    Yankelevitz DF
    J Thorac Oncol; 2018 Jan; 13(1):12-15. PubMed ID: 29162535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.